These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 33144565)

  • 1. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19.
    Abd El-Aziz TM; Al-Sabi A; Stockand JD
    Signal Transduct Target Ther; 2020 Nov; 5(1):258. PubMed ID: 33144565
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.
    Alhenc-Gelas F; Drueke TB
    Kidney Int; 2020 Jun; 97(6):1091-1093. PubMed ID: 32354636
    [No Abstract]   [Full Text] [Related]  

  • 3. Human recombinant soluble ACE2 in severe COVID-19.
    Zoufaly A; Poglitsch M; Aberle JH; Hoepler W; Seitz T; Traugott M; Grieb A; Pawelka E; Laferl H; Wenisch C; Neuhold S; Haider D; Stiasny K; Bergthaler A; Puchhammer-Stoeckl E; Mirazimi A; Montserrat N; Zhang H; Slutsky AS; Penninger JM
    Lancet Respir Med; 2020 Nov; 8(11):1154-1158. PubMed ID: 33131609
    [No Abstract]   [Full Text] [Related]  

  • 4. Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19.
    Leow MKS
    Crit Care; 2020 Jul; 24(1):396. PubMed ID: 32631373
    [No Abstract]   [Full Text] [Related]  

  • 5. Could DIZE be the answer to COVID-19?
    Qaradakhi T; Gadanec L; Matsoukas J; Apostolopoulos V; Zulli A
    Maturitas; 2020 Oct; 140():83-84. PubMed ID: 32636103
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral cancer and ACE2 receptor of SARS-CoV-2.
    Martelli-Júnior H; Machado RA; Martelli DRB; Andrade MC; Coletta RD
    Oral Oncol; 2020 Sep; 108():104920. PubMed ID: 32713810
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
    Prentice RE; Tjandra D; Garg M; Lubel JS; Fourlanos S; Johnson D; Al-Ani A; Christensen B
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1422-1423. PubMed ID: 33105980
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19: is the ACE2 just a foe?
    Jakovac H
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1025-L1026. PubMed ID: 32233935
    [No Abstract]   [Full Text] [Related]  

  • 9. Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome?
    Sama IE; Voors AA
    Eur Heart J; 2020 Jun; 41(32):3096. PubMed ID: 32577762
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasal ACE2 Levels and COVID-19 in Children.
    Patel AB; Verma A
    JAMA; 2020 Jun; 323(23):2386-2387. PubMed ID: 32432681
    [No Abstract]   [Full Text] [Related]  

  • 11. ACE2: The Only Thing That Matters?
    Sanchez-David RY; Swann OC; Peacock TP; Barclay WS
    Am J Respir Crit Care Med; 2020 Jul; 202(2):161-163. PubMed ID: 32520592
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients.
    Winkler T; Ben-David U
    Int J Cancer; 2020 Dec; 147(11):3264-3266. PubMed ID: 32525565
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19.
    Gue YX; Gorog DA
    Eur Heart J; 2020 Sep; 41(33):3198-3199. PubMed ID: 32691041
    [No Abstract]   [Full Text] [Related]  

  • 14. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.
    Pascolo L; Zupin L; Melato M; Tricarico PM; Crovella S
    J Dent Res; 2020 Sep; 99(10):1120-1121. PubMed ID: 32479133
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?
    Soldo J; Heni M; Königsrainer A; Häring HU; Birkenfeld AL; Peter A
    Diabetes Care; 2020 Oct; 43(10):e134-e136. PubMed ID: 32753456
    [No Abstract]   [Full Text] [Related]  

  • 16. ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19.
    Lupi L; Adamo M; Inciardi RM; Metra M
    Eur Heart J; 2020 Sep; 41(33):3200. PubMed ID: 32691039
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.
    Lim KH; Yang S; Kim SH; Joo JY
    J Infect; 2020 Sep; 81(3):e33-e34. PubMed ID: 32619698
    [No Abstract]   [Full Text] [Related]  

  • 18. New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease.
    Sama IE; Voors AA; van Veldhuisen DJ
    Eur Heart J; 2020 Nov; 41(41):4047-4049. PubMed ID: 33118012
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.
    Zhao Y; Zhao Z; Wang Y; Zhou Y; Ma Y; Zuo W
    Am J Respir Crit Care Med; 2020 Sep; 202(5):756-759. PubMed ID: 32663409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.